Pzena Investment Management’s Biogen BIIB Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-1,618
| Closed | -$461K | – | 162 |
|
|
2023
Q2 | $461K | Buy |
+1,618
| New | +$461K | ﹤0.01% | 144 |
|
|
2022
Q4 | – | Sell |
-2,384
| Closed | -$637K | – | 181 |
|
|
2022
Q3 | $637K | Hold |
2,384
| – | – | ﹤0.01% | 143 |
|
|
2022
Q2 | $486K | Hold |
2,384
| – | – | ﹤0.01% | 144 |
|
|
2022
Q1 | $502K | Buy |
+2,384
| New | +$502K | ﹤0.01% | 151 |
|
|
2020
Q4 | – | Sell |
-2,857
| Closed | -$810K | – | 167 |
|
|
2020
Q3 | $810K | Sell |
2,857
-386
| -12% | -$109K | 0.01% | 144 |
|
|
2020
Q2 | $868K | Sell |
3,243
-43,908
| -93% | -$11.8M | 0.01% | 147 |
|
|
2020
Q1 | $14.9M | Sell |
47,151
-2,519
| -5% | -$797K | 0.11% | 105 |
|
|
2019
Q4 | $14.7M | Buy |
49,670
+46,477
| +1,456% | +$13.8M | 0.07% | 116 |
|
|
2019
Q3 | $743K | Buy |
3,193
+875
| +38% | +$204K | ﹤0.01% | 156 |
|
|
2019
Q2 | $542K | Sell |
2,318
-133
| -5% | -$31.1K | ﹤0.01% | 157 |
|
|
2019
Q1 | $579K | Buy |
2,451
+345
| +16% | +$81.5K | ﹤0.01% | 155 |
|
|
2018
Q4 | $634K | Buy |
2,106
+242
| +13% | +$72.9K | ﹤0.01% | 155 |
|
|
2018
Q3 | $659K | Buy |
1,864
+74
| +4% | +$26.2K | ﹤0.01% | 162 |
|
|
2018
Q2 | $520K | Buy |
1,790
+43
| +2% | +$12.5K | ﹤0.01% | 150 |
|
|
2018
Q1 | $478K | Buy |
1,747
+816
| +88% | +$223K | ﹤0.01% | 146 |
|
|
2017
Q4 | $297K | Buy |
+931
| New | +$297K | ﹤0.01% | 151 |
|
|
2017
Q2 | – | Sell |
-759
| Closed | -$208K | – | 153 |
|
|
2017
Q1 | $208K | Buy |
+759
| New | +$208K | ﹤0.01% | 153 |
|
|
2016
Q4 | – | Sell |
-642
| Closed | -$201K | – | 159 |
|
|
2016
Q3 | $201K | Buy |
+642
| New | +$201K | ﹤0.01% | 149 |
|